Scynexis (SCYX) Change in Acquisitions & Divestments (2016 - 2026)
Scynexis (SCYX) posted Change in Acquisitions & Divestments of $2.8 million for Q1 2026, down 61.15% on a QoQ basis from $7.1 million in Q4 2025, and down 77.89% year-over-year from $12.4 million in Q1 2025.
Scynexis (SCYX) Change in Acquisitions & Divestments (2016 - 2026) Analysis & Trends
Scynexis' Change in Acquisitions & Divestments history runs 9 years deep, the most recent figure standing at $2.8 million for Q1 2026.
- Quarterly Change in Acquisitions & Divestments fell 77.89% year-over-year to $2.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $33.5 million (down 28.75% YoY) and the FY2025 annual result came in at $43.2 million, up 1.51% from the prior year.
- Change in Acquisitions & Divestments was $2.8 million for Q1 2026 at Scynexis, down from $7.1 million in the prior quarter.
- Across five years, Change in Acquisitions & Divestments topped out at $20.6 million in Q2 2023 and bottomed at $2.8 million in Q1 2026.
- A 4-year average of $11.6 million and a median of $10.7 million in 2023 frame the typical range for Change in Acquisitions & Divestments.
- Annual changes were most pronounced in 2025 — Change in Acquisitions & Divestments soared 56.2% — and 2026, when it plunged 77.89%.
- Scynexis' Change in Acquisitions & Divestments stood at $10.1 million in 2023, then plunged by 42.16% to $5.8 million in 2024, then advanced by 21.74% to $7.1 million in 2025, then slumped by 61.15% to $2.8 million in 2026.
- Business Quant data shows SCYX's Change in Acquisitions & Divestments at $2.8 million in Q1 2026, $7.1 million in Q4 2025, and $12.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.86 Bn | 88.00 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.96 Bn | 32.22 Bn | 1.97 Bn |
| 3 | Zoetis | 32.55 Bn | 30.61 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.56 Bn | 23.49 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.05 Bn | 20.90 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.75 Bn | 16.43 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.65 Bn | 12.22 Bn | 785.00 Mn |
| 10 | Scynexis | 23.19 Mn | -13.57 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.75 Mn |
| Mar 31, 2026 | 2.75 Mn |
| Dec 31, 2025 | 7.08 Mn |
| Dec 31, 2025 | 7.08 Mn |
| Sep 30, 2025 | 12.42 Mn |
| Sep 30, 2025 | 12.42 Mn |
| Jun 30, 2025 | 11.27 Mn |
| Jun 30, 2025 | 11.27 Mn |
| Mar 31, 2025 | 12.44 Mn |
| Mar 31, 2025 | 12.44 Mn |
| Dec 31, 2024 | 5.82 Mn |
| Dec 31, 2024 | 5.82 Mn |
| Sep 30, 2024 | 19.21 Mn |
| Sep 30, 2024 | 19.21 Mn |
| Jun 30, 2024 | 9.58 Mn |
| Jun 30, 2024 | 9.58 Mn |
| Mar 31, 2024 | 7.96 Mn |
| Mar 31, 2024 | 7.96 Mn |
| Dec 31, 2023 | 10.05 Mn |
| Dec 31, 2023 | 10.05 Mn |